» Authors » Matthew F Cusick

Matthew F Cusick

Explore the profile of Matthew F Cusick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 580
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Olp M, Laufer V, Valesano A, Zimmerman A, Woodside K, Lu Y, et al.
Life (Basel) . 2024 Sep; 14(9). PMID: 39337964
The human leukocyte antigen (HLA) system plays a pivotal role in the immune response to viral infections, mediating the presentation of viral peptides to T cells and influencing both the...
2.
Jiang C, Zhao L, Green M, Ravishankar S, Towlerton A, Scott A, et al.
Sci Rep . 2024 Jan; 14(1):345. PMID: 38172168
Immune checkpoint inhibitors (ICI) are important treatment options for metastatic non-small cell lung cancer (mNSCLC). However, not all patients benefit from ICIs and can experience immune-related adverse events (irAEs). Limited...
3.
Kueht M, Dongur L, Mujtaba M, Cusick M
J Pers Med . 2023 Jun; 13(6). PMID: 37373995
Donor-recipient matching is a highly individualized and complex component of solid organ transplantation. Flowcytometry crossmatching (FC-XM) is an integral step in the matching process that is used to detect pre-formed...
4.
Shea E, Sinicropi N, Cusick M, Rabah R, Lim H, Schumacher K, et al.
Transplant Proc . 2023 May; 55(8):1858-1861. PMID: 37188611
Background: Infections have been associated with rejection episodes in solid organ transplant recipients. We report an association between COVID-19 infection and heart transplant (HT) rejection. Case Description: The patient was...
5.
Ho C, Putnam K, Peiter C, Herczyk W, Gerlach J, Lu Y, et al.
J Clin Med . 2022 Oct; 11(20). PMID: 36294380
We report the first case of Daratumumab interference of allogeneic crossmatch tests repeatedly causing aberrant false-positive results, which inadvertently delayed transplant for a waitlisted renal patient with multiple myeloma. Daratumumab...
6.
Hod-Dvorai R, Cusick M
Hum Immunol . 2022 Feb; 83(10):704-711. PMID: 35120770
Unrelated allogeneic hematopoietic cell transplant (HCT) is a critical modality to treat hematologic malignancies. The current objective of donor selection is to match donor and recipient at the HLA (human...
7.
Cusick M, Clark L, Tu T, Goforth J, Zhang X, LaRue B, et al.
Hum Immunol . 2021 Nov; 83(1):61-69. PMID: 34728094
Chimerism testing provides informative clinical data regarding the status of a biological sample mixture. For years, this testing was achieved by measuring the peaks of informative short tandem repeat (STR)...
8.
Jindra P, Cusick M
Clin Lab Med . 2019 Feb; 39(1):107-123. PMID: 30709500
There is growing evidence supporting the genetic variability outside of HLA system that is contributing to the variation in transplant outcomes. Determining novel predictors could help to identify patients at...
9.
Cusick M, Jindra P
Clin Lab Med . 2018 Nov; 38(4):595-605. PMID: 30420055
HLA epitope matching provides a better approach to stratify patients at risk of developing antibody-mediated rejection compared with counting HLA mismatches. However, several immunologic parameters are not incorporated into these...
10.
Cusick M, Libbey J, Doty D, DePaula-Silva A, Fujinami R
J Neurovirol . 2017 Jul; 23(5):696-703. PMID: 28741149
Seizure disorders are often associated with infectious etiologies. Infection, via the intracerebral (i.c.) route, of C57BL/6J mice with the Daniels (DA) strain of Theiler's murine encephalomyelitis virus (TMEV) results in...